MIR155HG

ncRNA information

ncRNA name

MIR155HG

Specific or universal ncRNAs

Specific ncRNAs

Class

Long noncoding RNA

Biomarker

None

Biomarker application

Upstream regulatory factors

Not available

Downstream target

PTBP1

Cancer information

Cancer name

Glioma

Cancer site

None

Treatment information

Treatment type

Chemotherapy

Drug

Temozolomide

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

LncRNA MIR155HG Promotes Temozolomide Resistance by Activating the Wnt/Ī²-Catenin Pathway Via Binding to PTBP1 in Glioma

Tissue resource

Experiment

None


Institute

Country

Continent